Lantern Pharma Announces Publication Detailing Preclinical Results of Drug Candidate, LP-184, in a Spectrum of Drug-Resistant Lung Cancers in the Journal Oncotarget
Stock Information for Lantern Pharma Inc.
Loading
Please wait while we load your information from QuoteMedia.